List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 988 studies with search of:   "Sanofi-Aventis" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Insulin Glargine in Type 2 Diabetic Patients
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine;   Drug: Glyburide;   Drug: Glyclazide;   Drug: Glimiperide;   Drug: Glipizide;   Drug: Metformin
2 Completed A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.
Condition: Acne Vulgaris
Interventions: Drug: clindamycin 1% / benzoyl peroxide 5% gel pump;   Drug: clindamycin 1% / benzoyl peroxide 5% tube
3 Active, not recruiting Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin
4 Completed To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
Condition: Breast Neoplasms
Intervention: Drug: Docetaxel
5 Recruiting Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide (HMR1726);   Drug: Placebo
6 Recruiting Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties
Condition: Sleep Initiation and Maintenance Disorders
Interventions: Drug: eplivanserin (SR46349);   Drug: lormetazepam
7 Completed Dermacyd Teen Care Tangerina Mix - Compatibility
Condition: Hygiene
Intervention: Drug: Lactic acid
8 Completed Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
Condition: Diabetes Mellitus
Interventions: Drug: Lantus (insulin glargine [rDNA origin] injection);   Drug: Humulin N;   Drug: Humulin L;   Drug: Lispro
9 Completed An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
Condition: Depressive Disorder
Intervention: Drug: Saredutant succinate (SR48968C)
10 Completed Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
Conditions: Influenza;   Orthomyxoviridae Infections
Intervention: Biological: A/H5N1 inactivated, split-virion influenza virus
11 Enrolling by invitation Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
12 Recruiting GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: AVE0010;   Drug: Placebo
13 Terminated Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Risedronate;   Drug: Raloxifene;   Other: Placebo
14 Completed Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: gemcitabine/Eloxatin (GEMOX);   Drug: carboplatin/paclitaxel (CP)
15 Completed Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Condition: Esophageal Neoplasms
Intervention: Drug: Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)
16 Completed Riluzole in Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Riluzole
17 Completed Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.
Condition: Alzheimer Disease
Intervention: Drug: AVE1625
18 Terminated ALF-STONE: Alfuzosin in Uretheric Stones
Condition: Prostatic Hyperplasia
Intervention: Drug: Alfuzosin
19 Completed Glulisine + Lantus in Type I Patients
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insuline Glulisine
20 Active, not recruiting Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone Vaccine
Condition: Influenza
Intervention: Biological: 2007-2008 Influenza Virus Vaccine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services